Suppr超能文献

评估患有慢性疾病的患者中潜在药物-药物相互作用的相关风险因素。

Assessment of risk factors associated with potential drug-drug interactions among patients suffering from chronic disorders.

机构信息

Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan.

Department of Clinical Pharmacy, School of Pharmaceutical Sciences, University Sains Malaysia, Penang, Malaysia.

出版信息

PLoS One. 2023 Jan 24;18(1):e0276277. doi: 10.1371/journal.pone.0276277. eCollection 2023.

Abstract

Patients suffering from chronic diseases are more likely to experience pDDIs due to older age, prolonged treatment, severe illness and greater number of prescribed drugs. The objective of the current study was to assess the prevalence of pDDIs and risk factors associated with occurrence of pDDIs in chronic disease patients attending outpatient clinics for regular check-ups. Patients suffering from diabetes, chronic obstructive pulmonary disease (COPD), stroke and osteoporosis were included in the study. This study was a cross sectional, observational, prospective study that included 337 patients from outpatient clinics of respiratory ward, cardiac ward and orthopedic ward of Nishter Hospital Multan, Pakistan. The mean number of interactions per patient was 1.68. A greater risk for occurrence of pDDI was associated with older age ≥ 60 years (OR = 1.95, 95% CI = 1.44-2.37, p<0.001); polypharmacy (≥ 5 drugs) (OR = 3.74, 95% CI 2.32-4.54, p<0.001); overburden (OR = 2.23, 95% CI = 1.64-3.16, p<0.01); CCI score (OR = 1.28, 95% CI = 1.04-1.84, p<0.001); multiple prescribers to one patient (OR = 1.18, 95% CI = 1.06-1.41, p<0.01); and trainee practitioner (OR = 1.09, 95% CI = 1.01-1.28, p<0.01). Old age, polypharmacy, overburden healthcare system, higher comorbidity index, multiple prescribers to one patient and trainee practitioner were associated with increased risk of occurrence of pDDIs in chronic disease patients.

摘要

患有慢性病的患者由于年龄较大、治疗时间长、病情严重和服用的药物数量较多,更容易发生潜在药物相互作用。本研究的目的是评估慢性病患者在门诊定期检查时发生潜在药物相互作用的患病率和相关风险因素。研究纳入了糖尿病、慢性阻塞性肺疾病(COPD)、中风和骨质疏松症患者。本研究为横断面、观察性、前瞻性研究,纳入了来自巴基斯坦木尔坦尼什特医院呼吸病房、心脏病房和骨科病房的 337 名门诊患者。每位患者的平均相互作用数为 1.68。发生潜在药物相互作用的风险较高与年龄≥60 岁(OR=1.95,95%CI=1.44-2.37,p<0.001);多药治疗(≥5 种药物)(OR=3.74,95%CI 2.32-4.54,p<0.001);负担过重(OR=2.23,95%CI=1.64-3.16,p<0.01);CCI 评分(OR=1.28,95%CI=1.04-1.84,p<0.001);一名患者有多个开方医生(OR=1.18,95%CI=1.06-1.41,p<0.01);和实习医生(OR=1.09,95%CI=1.01-1.28,p<0.01)。年龄较大、多药治疗、医疗保健系统负担过重、较高的合并症指数、一名患者有多个开方医生和实习医生与慢性病患者发生潜在药物相互作用的风险增加相关。

相似文献

1
Assessment of risk factors associated with potential drug-drug interactions among patients suffering from chronic disorders.
PLoS One. 2023 Jan 24;18(1):e0276277. doi: 10.1371/journal.pone.0276277. eCollection 2023.
2
Risk factors for potential drug-drug interactions in patients with chronic obstructive pulmonary disease.
Ir J Med Sci. 2020 Aug;189(3):1123-1125. doi: 10.1007/s11845-019-02155-9. Epub 2019 Dec 5.
3
Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
Int J Clin Pharm. 2013 Jun;35(3):455-62. doi: 10.1007/s11096-013-9764-1. Epub 2013 Mar 13.
4
Are patients with a nasally placed feeding tube at risk of potential drug-drug interactions? A multicentre cross-sectional study.
PLoS One. 2019 Jul 31;14(7):e0220248. doi: 10.1371/journal.pone.0220248. eCollection 2019.
5
Review of prescription medications in home-based older adults with stroke: a pilot study.
Res Social Adm Pharm. 2007 Mar;3(1):104-22. doi: 10.1016/j.sapharm.2006.06.002.
6
The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan.
Saudi Pharm J. 2020 Feb;28(2):155-160. doi: 10.1016/j.jsps.2019.11.009. Epub 2019 Dec 7.
7
Evaluation of Drug-Related Problems in Chronic Kidney Disease Patients.
Cureus. 2022 Apr 10;14(4):e24019. doi: 10.7759/cureus.24019. eCollection 2022 Apr.
10
Clinical Pertinence and Determinants of Potential Drug-Drug Interactions in Chronic Kidney Disease Patients: A Cross-sectional Study.
J Pharm Technol. 2024 Jun;40(3):142-151. doi: 10.1177/87551225241241977. Epub 2024 Apr 3.

引用本文的文献

1
4
Risk Factors and Patterns of Drug-Drug Interactions in Two Categories of Level-3 Hospitals in Dhaka: A Cross-Sectional Study.
Health Sci Rep. 2025 Jan 14;8(1):e70355. doi: 10.1002/hsr2.70355. eCollection 2025 Jan.
6
The direct cost of chronic kidney disease (CKD) reported in Asian countries; a systematic literature review.
Cost Eff Resour Alloc. 2024 Sep 5;22(1):65. doi: 10.1186/s12962-024-00566-9.
9
Potential Drug-Drug Interactions and Related Factors among Geriatric Outpatients of a Tertiary Care Hospital.
Geriatrics (Basel). 2023 Nov 14;8(6):111. doi: 10.3390/geriatrics8060111.
10
Risk Factors for Potential Drug-Drug Interactions in Outpatients with Dyslipidemia.
Iran J Public Health. 2023 Jul;52(7):1466-1475. doi: 10.18502/ijph.v52i7.13248.

本文引用的文献

1
Barriers and facilitators to pharmacovigilance activities in Pakistan: A healthcare professionals-based survey.
PLoS One. 2022 Jul 29;17(7):e0271587. doi: 10.1371/journal.pone.0271587. eCollection 2022.
3
Humanistic and socioeconomic burden of COPD patients and their caregivers in Malaysia.
Sci Rep. 2021 Nov 19;11(1):22598. doi: 10.1038/s41598-021-01551-5.
4
5
Risk Factors Associated With Medication Errors Among Patients Suffering From Chronic Disorders.
Front Public Health. 2020 Nov 19;8:531038. doi: 10.3389/fpubh.2020.531038. eCollection 2020.
6
7
Burden of communicable diseases and cost of illness: Asia pacific region.
Expert Rev Pharmacoecon Outcomes Res. 2020 Aug;20(4):343-354. doi: 10.1080/14737167.2020.1782196. Epub 2020 Jun 23.
8
A Qualitative Evaluation of Adverse Drug Reaction Reporting System in Pakistan: Findings from the Nurses' Perspective.
Int J Environ Res Public Health. 2020 Apr 27;17(9):3039. doi: 10.3390/ijerph17093039.
9
Economic Burden of Chronic Obstructive Pulmonary Disease Patients in Malaysia: A Longitudinal Study.
Pharmacoecon Open. 2021 Mar;5(1):35-44. doi: 10.1007/s41669-020-00214-x.
10
Physicians' Understanding and Practices of Pharmacovigilance: Qualitative Experience from A Lower Middle-Income Country.
Int J Environ Res Public Health. 2020 Mar 25;17(7):2209. doi: 10.3390/ijerph17072209.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验